IRWD Ironwood appoints Dr. Jeffrey silber chief Medical officer and head of research and drug development; stars-2 trial initiated in June a

IRWD Ironwood appoints Dr. Jeffrey silber chief Medical officer and head of research and drug development; stars-2 trial initiated in June and is now actively recruiting patients Ironwood Pharmaceuticals - initiates phase 3 stars-2 trial of apraglutide in June, now recruiting patients